Clinical obstetrics and gynecologyHumansFetal Growth RetardationPregnancyFemalePlacenta Growth Factor
The Role of Angiogenic Factors in Fetal Growth Restriction.
Helena C Bartels, Sebastian R Hobson
Published: 202510.1097/GRF.0000000000000972
Abstract
Fetal growth restriction complicates up to 10% of pregnancies, resulting in significant morbidity and mortality. Biomarkers of placental function, such as PIGF or the sFLT-1/PlGF ratio, are increasingly used in clinical practice, as an adjunct to ult…
Preview only. Read the full abstract at the source